Cannabis Fortunes are in the Making

We are definitely in the early stages of cannabis investing and the infrastructure building stages of the marijuana sector where fortunes will be made.

I can tell you with 100% certainty that fortune favors the bold, and those that are nimble enough to go with the trend will benefit the most.

The U.N. estimates the cannabis market to be $150 billion globally. This is a sector going from the black market prohibition into a regulated legal environment with miles of inroads and infrastructure to build out and piles of wealth to be made.

With states across the U.S. legalizing cannabis, along with countries like Canada federally legalizing recreational cannabis, we are beyond the tipping point.

Across North America, marijuana is having its best year ever. Support for legalizing weed across the U.S. is at its highest level in years—polls find as much as 80 percent in favor.

The stigma around cannabis is being completely removed.

People are learning that it’s much safer than alcohol, cigarettes, and certainly superior to hard drugs such as heroine, cocaine, and methamphetamines from a health perspective.

The FDA has recently approved the first ever drug based on cannabis. And now that it’s being decriminalized, it’s going to be available to study and fully explore the health benefits, unlike any other time in history.

The expansive list for medical benefits include, but are not limited to:

-Chronic pain

-Muscle spasms

-Treating glaucoma

-Epileptic seizures

-Cancer treatment


-Alzheimer’s disease

-Easing the pain of multiple sclerosis

-And more…

In many ways, it’s become a panacea for many ailments. More importantly, though, the mass public is learning about this, and a massive shift in attitude towards cannabis is sweeping throughout the world.

The rise in public cannabis stocks has been absolutely meteoric.

This is still only the beginning.

The world has yet to fully be introduced to the next Philip Morris or Anheuser Busch of the cannabis space. In due time, the legacy stocks that will be handed down to our children and grandchildren will begin to surface as the dominators and will be 100% apparent.

For now, the industry is still super immature, which is why I’m getting fully invested in the space with companies that offer the most upside, with a tsunami of a trend backing them.

After an incredible amount of due diligence and vetting, I’m proud to announce my next cannabis pick, C21 Investments Inc. (CSE:CXXI), a Vancouver-based corporation focused on the cultivation, manufacturing, processing, and distribution of quality cannabis throughout the United States, including non-hemp derived CBD products that are distributable throughout North America and the international markets.

In order to benefit from the entire cannabis business cycle, I wanted to select a company that practices full vertical integration, and that’s precisely what C21 Investments Inc. does. No part of the cycle is untouched, as C21 Investments Inc. excels as an ecosystem of leading businesses in strategic markets focused on value creation through supply chain optimization, quality manufacturing, brand extension, and distribution and retail channels:

Courtesy of

Rather than profit from only one aspect of the cannabis market, C21 Investments Inc. capitalizes on the entire process, from production all the way through distribution. This is an A-Z business model, with the company making acquisitions and operating along the entire spectrum of the cannabis space, capturing profit margins through the entire value chain.

This is an incredibly aggressive strategy that offers the potential of high rewards for savvy investors!

For C21 Investments Inc., only the best will do when it comes to value-added acquisitions. These acquisitions include dispensary 7 Leaf, which has developed a loyal following of roughly 2,000 customers per month; Pure Green, a 3,000-sqare-foot retail dispensary serving over 2,500 loyal customers per month along Portland’s “Green Mile”; Eco Firma Farms, an approximately 20-acre cultivation site with a building structure providing approximately 26,000 square feet of available indoor grow, processing, and office space; Swell, a grower, extractor, manufacturer, and distributor in a high-growth cannabis sector of THC and CBD products within Oregon; Phantom Farms Cannabis Co., which cultivates 80,000 square feet of cannabis in the famous Rogue Valley in southern Oregon, and will undergo further expansion of 40,000 square feet in its 2018 cultivation operations; and Nevada dispensary Silver State Relief, which has generated approximately USD$15 million in revenue during the first six months of 2018.

This is only the beginning!

This is extremely impressive, but it’s just the tip of the iceberg, and we’re going to see plenty of expansion with C21 Investments Inc. in 2018. The firm’s current holdings are just the beginning, pas the firm has multiple targeted acquisitions planned:

Courtesy of

The route to massive success is being forged right now, and first-mover status is absolutely critical for anyone who plans to make the really big money. Much like the legalized cannabis industry itself, C21 Investments Inc. has had an amazing 2018 so far, and the blue sky is the limit.

Immediately consider taking a position in C21 Investments Inc. (CSE:CXXI)!

This is truly a cannabis investment vehicle that’s destined to move fast and go far.

One thing my readers know without a shadow of a doubt is that cannabis is one of the biggest stories of 2018. Many will experience the truly phenomenal profits to be made in the space if they are sensitive and willing to move with the trends.

The trend here in 2018 in heavily in cannabis.

The move from illegal to legal is happening at a rapid pace.

A report from Arcview Market Research and BDS Analytics found that cannabis sales accounted for $9.5 billion in consumer spending.

The total size of the global cannabis market is estimated to reach $32 billion by 2022 and $57 billion by 2027.

We’re largely moving away from cannabis being a Republican or Democrat divisive issue. Many states are racing towards legalization, and even ultra-conservative Oklahoma, for instance, just legalized medical marijuana, becoming the 30th state to do so.

States like Oklahoma are desperate for tax revenue… the kind that a new green pot industry could generate.

And once governments get hooked on the tax revenues from weed, there is no going back…

There is going to be a scramble for profits in the cannabis space like we’ve never seen before, and you might as well have a front-row seat to the show.

We will talk about the early days of cannabis that we are seeing right now decades down the road, and if you’re reading this now, you might as well have something to show for it beyond just some anecdotal story…

Act today…

Prosperous Regards,

Kenneth Ameduri

Chief Editor of

Legal Notice

This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

Never base any decision off of our emails. stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. We have been compensated by C21 Investments Inc. a digital marketing fee of three hundred thousand dollars USD. We have also received a signing fee of five hundred thousand dollars CAD. We have also been issued one million eight hundred thousand RSUs. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at